NL-OMON25226招募中不适用
A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home
MC Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Age =40 years
- •2) Cardiovasculair risk profile or cardiovascular disease (overweight, hypertension, diabetes, smoking, coronary artery disease, previous myocardial infarction, heart failure)
- •3) Presumably COVID-19 (both SARS-CoV-2 positive and non-COVID-19 confirmed patients)
- •4) Moderate-severe symptoms
- •5) Mentally competent
排除标准
- •1) Severe illness requiring hospital admission
- •2) Patient does not want future hospitalisation
- •3) Known anemia
- •4) Inadequate mastery of the Dutch language
- •5) Not willing to sign informed consent
- •6) Not willing to adhere to study procedures
研究者
相似试验
已完成
不适用
A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at homeNL-OMON54917niversitair Medisch Centrum Utrecht50
已完成
不适用
Culturally informed assessment and treatment of chronic paiChronic PainPhysical Medicine / Rehabilitation - PhysiotherapyACTRN12616000857404iverpool Hospital48
尚未招募
不适用
A mobile health application for people in remote and rural Queensland who have experienced a cardiovascular event.Coronary Heart DiseaseCardiovascular - Coronary heart diseaseCardiovascular diseaseACTRN12621001229864Menzies Health Institute Queensland (MHIQ)60
已完成
不适用
Self-management and Multiple Sclerosis: The impact of a community-based exercise and education programMultiple SclerosisACTRN12613000245796Melbourne Health24
进行中（未招募）
2 期
Permissive HyperthErmia Through Avoidance of Paracetamol in Known or Suspected Infection in the Intensive Care Unit (ICU) - pilot studyACTRN12611000981921Medical Research Institute of New Zealand30